Retro

The AI engine Fit Assessment

Beta

Retro Biosciences is focused on developing therapeutics that target the cellular mechanisms of aging, including cellular reprogramming and autophagy. Their mission is to enhance healthy human lifespan by addressing age-related diseases through innovative research and development.

Blurb

Retro Biosciences focus on cellular reprogramming, autophagy and plasma-inspired therapeutics.

HQ Location

San Francisco (United States)

Founded

2021

Employees

56

Total funding raised

$180.00M

Last Funding Event

Pre-Seed, $180.00M, April 6, 2022

Smart insights

  • 6m headcount growth: 11%
  • 1Y headcount growth: 32%
  • Headcount-to-last-round ratio: 0.3 employees/$M

Developer of cellular reprogramming, autophagy, and plasma-inspired therapeutics intended to increase healthy human lifespan. The company focuses on the research and development of anti-aging therapeutics using cell transcriptomics which targets multiple mechanisms of aging, enabling patients to prevent age-related diseases, thereby enhancing their life span.